Uncategorized

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can increase the risk of heart attacks and strokes.
Many Americans are unaware that elevated levels of this particle — known as lipoprotein(a) or Lp(a) — are circulating in their blood.
Elevated Lp(a) cannot be modified with lifestyle changes, and has been called “one of the last untreatable frontiers of cardiovascular risk” by Cleveland Clinic, who led the study.
LOW-CARB KETO DIET MAY NOT RAISE HEART DISEASE RISK, NEW STUDY SUGGESTS
This new research confirmed earlier findings showing that the experimental drug — lepodisiran, made by Eli Lilly, who funded the study — can “silence” the main gene responsible for synthesizing Lp(a).
(Other experimental gene therapies with a similar mechanism of action are also in development, according to Cleveland Clinic.)
The findings were published in The New England Journal of Medicine and were also presented at the annual m..

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can increase the risk of heart attacks and strokes.
Many Americans are unaware that elevated levels of this particle — known as lipoprotein(a) or Lp(a) — are circulating in their blood.
Elevated Lp(a) cannot be modified with lifestyle changes, and has been called “one of the last untreatable frontiers of cardiovascular risk” by Cleveland Clinic, who led the study.
LOW-CARB KETO DIET MAY NOT RAISE HEART DISEASE RISK, NEW STUDY SUGGESTS
This new research confirmed earlier findings showing that the experimental drug — lepodisiran, made by Eli Lilly, who funded the study — can “silence” the main gene responsible for synthesizing Lp(a).
(Other experimental gene therapies with a similar mechanism of action are also in development, according to Cleveland Clinic.)
The findings were published in The New England Journal of Medicine and were also presented at the annual m..

Martin Zubimendi’s long-term future is uncertain, as Real Madrid enter the race for the Spain international, who has been subject to strong interest from Arsenal

How the Arsenal kits in 2025/26 could look if AI was in control of the designs

How the Spurs kits in 2025/26 could look if AI was in control of the designs

How the Chelsea kits in 2025/26 could look if AI was in control of the designs

A Chelsea cult hero has been sporting a new look since he left Stamford Bridge almost 10 years ago

The latest Arsenal news as the youngster is highly-rated at the Emirates Stadium, but is unable to make his Premier League debut this season

The latest Chelsea transfer news and rumours as speculation around Victor Osimhen continues to spiral.

The latest on Manchester City’s 115+ Premier League charges case from a football finance expert amid expectation that a decision will become public soon